Cargando…
Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men
INTRODUCTION: Failure of fluoroquinolones, the principal treatment option for macrolide-resistant Mycoplasma genitalium infections, has recently emerged. This is of particular concern for men who have sex with men (MSM), who have high proportions of macrolide-resistant M. genitalium infections. Trea...
Autores principales: | Chua, Teck-Phui, Bodiyabadu, Kaveesha, Machalek, Dorothy A., Garland, Suzanne M., Bradshaw, Catriona S., Plummer, Erica L., Danielewski, Jennifer, Vodstrcil, Lenka A., Doyle, Michelle L., Murray, Gerald L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697509/ https://www.ncbi.nlm.nih.gov/pubmed/34590993 http://dx.doi.org/10.1099/jmm.0.001429 |
Ejemplares similares
-
gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy
por: Murray, Gerald L, et al.
Publicado: (2023) -
Detection of parC gene mutations associated with quinolone resistance in Mycoplasma genitalium: evaluation of a multiplex real-time PCR assay
por: Bodiyabadu, Kaveesha, et al.
Publicado: (2021) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium
por: Durukan, Duygu, et al.
Publicado: (2020) -
Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men
por: Read, Tim R.H., et al.
Publicado: (2019)